Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Hoofdauteurs: | Baird, J, Rieckmann, K |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2003
|
Gelijkaardige items
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
door: Baird, J
Gepubliceerd in: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
door: Baird, J
Gepubliceerd in: (1998) -
Primaquine therapy for malaria.
door: Baird, J, et al.
Gepubliceerd in: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
door: Krudsood, S, et al.
Gepubliceerd in: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
door: Luzzi, G, et al.
Gepubliceerd in: (1992)